Gut Microbiome Disruption Following SARS-CoV-2: A Review
Elda Righi, Ilaria Dalla Vecchia, Nina Auerbach, Matteo Morra, Anna Górska, Concetta Sciammarella, Lorenza Lambertenghi, Elisa Gentilotti, Massimo Mirandola, Evelina Tacconelli, Assunta Sartor
Microorganisms, doi:10.3390/microorganisms12010131
COVID-19 has been associated with having a negative impact on patients' gut microbiome during both active disease and in the post-acute phase. In acute COVID-19, rapid alteration of the gut microbiome composition was observed, showing on one side a reduction in beneficial symbionts (e.g., Roseburia, Lachnospiraceae) and on the other side an increase in opportunistic pathogens such as Enterococcus and Proteobacteria. Alpha diversity tends to decrease, especially initially with symptom onset and hospital admission. Although clinical recovery appears to align with improved gut homeostasis, this process could take several weeks, even in mild infections. Moreover, patients with COVID-19 post-acute syndrome showed changes in gut microbiome composition, with specific signatures associated with decreased respiratory function up to 12 months following acute disease. Potential treatments, especially probiotic-based therapy, are under investigation. Open questions remain on the possibility to use gut microbiome data to predict disease progression and on potential confounders that may impair result interpretation (e.g., concomitant therapies in the acute phase; reinfection, vaccines, and occurrence of novel conditions or diseases in the post-acute syndrome). Understanding the relationships between gut microbiome dynamics and disease progression may contribute to better understanding post-COVID syndrome pathogenesis or inform personalized treatment that can affect specific targets or microbiome markers.
Conflicts of Interest: The authors declare no conflicts of interest.
References
Alenazy, Aljohar, Alruwaili, Daghestani, Alonazi et al., Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications, Metabolites,
doi:10.3390/metabo12100912Allie, Bradley, Mudunuru, Schultz, Graf et al., The establishment of resident memory B cells in the lung requires local antigen encounter, Nat. Immunol,
doi:10.1038/s41590-018-0260-6Baud, Dimopoulou Agri, Gibson, Reid, Giannoni, Using probiotics to flatten the curve of coronavirus disease COVID-2019 pandemic, Front. Public Health,
doi:10.3389/fpubh.2020.00186Bili Ński, Winter, Jasi Ński, Szczęś, Bilinska et al., Rapid resolution of COVID-19 after faecal microbiota transplantation, Gut,
doi:10.1136/gutjnl-2021-325010Carneiro, Littlefield, Watson, Palmer, Lozupone, Inflammation-associated gut microbiome in postacute sequelae of SARS-CoV-2 points towards new therapeutic targets, Gut,
doi:10.1136/gutjnl-2022-328757Ceccarelli, Borrazzo, Pinacchio, Santinelli, Innocenti et al., Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study, Front. Nutr,
doi:10.3389/fnut.2020.613928Cheng, Zhang, Li, Wu, Wu et al., Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases, BMC Microbiol,
doi:10.1186/s12866-022-02686-9Davani-Davari, Negahdaripour, Karimzadeh, Seifan, Mohkam et al., Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications, Foods,
doi:10.3390/foods8030092De Nies, Galata, Martin-Gallausiaux, Despotovic, Busi et al., Altered infective competence of the human gut microbiome in COVID-19, Microbiome,
doi:10.1186/s40168-023-01472-7Din, Mazhar, Waseem, Ahmad, Bibi et al., SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role, Biomed Pharmacother. Biomed. Pharmacother,
doi:10.1016/j.biopha.2020.110947Gaibani, D'amico, Bartoletti, Lombardo, Rampelli et al., The Gut Microbiota of Critically Ill Patients With COVID-19, Front. Cell Infect. Microbiol,
doi:10.3389/fcimb.2021.670424Gentilotti, Górska, Tami, Gusinow, Mirandola et al., Clinical phenotypes and quality of life to define post-COVID-19 syndrome: A cluster analysis of the multinational, prospective ORCHESTRA cohort, EClinicalMedicine,
doi:10.1016/j.eclinm.2023.102107Gutiérrez-Castrellón, Gandara-Martí, Abreu Yabreu, Nieto-Rufino, López-Orduña et al., Probiotic improves symptomatic and viral clearance in Covid19 outpatients: A randomized, quadruple-blinded, placebo-controlled trial, Gut Microbes,
doi:10.1080/19490976.2021.2018899Hegazy, Ahmed Ashoush, Tharwat Hegazy, Wahba, Lithy et al., Beyond probiotic legend: ESSAP gut microbiota health score to delineate SARS-COV-2 infection severity, Br. J. Nutr,
doi:10.1017/S0007114521001926Hill, Guarner, Reid, Gibson, Merenstein et al., The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat. Rev. Gastroenterol. Hepatol,
doi:10.1038/nrgastro.2014.66Hu, Zhang, Lin, Tang, Chan et al., Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic, Trends Food Sci. Technol,
doi:10.1016/j.tifs.2020.12.009Huang, Huang, Wang, Li, Ren et al., 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study, Lancet Lond. Engl,
doi:10.1016/S0140-6736(20)32656-8Huerta-Cepas, Serra, Bork, ETE 3: Reconstruction, Analysis, and Visualization of Phylogenomic Data, Mol. Biol. Evol,
doi:10.1093/molbev/msw046Huson, Beier, Flade, Górska, El-Hadidi et al., MEGAN Community Edition-Interactive Exploration and Analysis of Large-Scale Microbiome Sequencing Data, PLoS Comput. Biol,
doi:10.1371/journal.pcbi.1004957Johnson, Hage, Kalveram, Mears, Plante et al., Peptidoglycan-Associated Cyclic Lipopeptide Disrupts Viral Infectivity, J. Virol,
doi:10.1128/JVI.01282-19Jones, Oliphant, Peterson, SciPy: Open Source Scientific Tools for Python
Kim, Joo, Lee, Ahn, Kim et al., Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study, Microorganisms,
doi:10.3390/microorganisms9061237Kim, Kim, Kim, Gut microbiota restoration through fecal microbiota transplantation: A new atopic dermatitis therapy, Exp. Mol. Med,
doi:10.1038/s12276-021-00627-6Liu, Mak, Su, Yeoh, Lui et al., Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome, Gut,
doi:10.1136/gutjnl-2021-325989Liu, Su, Zhang, Tun, Mak et al., Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome, Nat. Commun,
doi:10.1038/s41467-022-34535-8Liu, Ye, Zhu, He, Wang et al., Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients, J. Med. Case Rep,
doi:10.1186/s13256-020-02583-7Mazzarelli, Giancola, Farina, Marchioni, Rueca et al., 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19, PLoS ONE,
doi:10.1371/journal.pone.0247041Moreira-Rosário, Marques, Pinheiro, Araújo, Ribeiro et al., Gut Microbiota Diversity and C-Reactive Protein Are Predictors of Disease Severity in COVID-19 Patients, Front. Microbiol,
doi:10.3389/fmicb.2021.705020Newsome, Gauthier, Hernandez, Abraham, Robinson et al., The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort, Gut Microbes,
doi:10.1080/19490976.2021.1926840Oliva, Di Nardo, Ferrari, Mallardo, Rossi et al., Randomised clinical trial: The effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis, Aliment. Pharmacol. Ther,
doi:10.1111/j.1365-2036.2011.04939.xParker, Wearsch, Veloo, Rodriguez-Palacios, The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health, Front. Immunol,
doi:10.3389/fimmu.2020.00906Piscotta, Hoffmann, Choi, Small, Ashbrook et al., Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals, Msphere,
doi:10.1128/mSphere.00711-21Quast, Pruesse, Yilmaz, Gerken, Schweer et al., The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools, Nucleic Acids Res,
doi:10.1093/nar/gks1219Reinold, Farahpour, Fehring, Dolff, Konik et al., A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19, Front. Cell Infect. Microbiol,
doi:10.3389/fcimb.2021.747816Righi, Lambertenghi, Gorska, Sciammarella, Ivaldi et al., Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp, Biomedicines,
doi:10.3390/biomedicines10112786Righi, Mirandola, Mazzaferri, Dossi, Razzaboni et al., Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study, J. Infect,
doi:10.1016/j.jinf.2022.02.003Righi, Mirandola, Mazzaferri, Razzaboni, Zaffagnini et al., Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19, Infect. Dis. Ther,
doi:10.1007/s40121-021-00461-3Su, Lau, Liu, Chan, Ng, Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance, Gut,
doi:10.1136/gutjnl-2022-328319Takahashi, Tomita, Nishioka, Hisada, Nishijima, Development of a prokaryotic universal primer for simultaneous analysis of Bacteria and Archaea using next-generation sequencing, PLoS ONE,
doi:10.1371/journal.pone.0105592Vestad, Ueland, Lerum, Dahl, Holm et al., Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations, J. Intern. Med,
doi:10.1111/joim.13458Wischmeyer, Tang, Ren, Bohannon, Ramirez et al., Efficacy of Probiotic Treatment as Post-Exposure Prophylaxis for COVID-19: A Double-Blind, Placebo Controlled Randomized Tria
Wong, Zhang, Ching, Mak, Huang et al., Effects of Gut Microbiome Modulation on Reducing Adverse Health Outcomes among Elderly and Diabetes Patients during the COVID-19 Pandemic: A Randomised, Double-Blind, Placebo-Controlled Trial (IMPACT Study), Nutrients,
doi:10.3390/nu15081982Yeoh, Zuo, Lui, Zhang, Liu et al., Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19, Gut,
doi:10.1136/gutjnl-2020-323020Zhang, Han, Li, Chen, Xie et al., Probiotics use is associated with improved clinical outcomes among hospitalized patients with COVID-19, Ther. Adv. Gastroenterol,
doi:10.1177/17562848211035670Zhang, Lau, Liu, Su, Chan et al., Gut microbiota in COVID-19: Key microbial changes, potential mechanisms and clinical applications, Nat. Rev. Gastroenterol. Hepatol,
doi:10.1038/s41575-022-00698-4Zhang, Xu, Mak, Chow, Lui et al., Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study, J. Gastroenterol. Hepatol,
doi:10.1111/jgh.15796Zhang, Zhou, Ma, Chen, Tang et al., Gut Microbiota Dysbiosis Correlates With Long COVID-19 at One-Year After Discharge, J. Korean Med. Sci,
doi:10.3346/jkms.2023.38.e120Zhou, Zhang, Zhang, Ma, Wang, Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge, J. Microbiol,
doi:10.1007/s12275-021-1206-5Zuo, Zhan, Zhang, Liu, Tso et al., Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge, Gastroenterology,
doi:10.1053/j.gastro.2020.06.048{ 'indexed': {'date-parts': [[2024, 1, 11]], 'date-time': '2024-01-11T00:11:37Z', 'timestamp': 1704931897611},
'reference-count': 60,
'publisher': 'MDPI AG',
'issue': '1',
'license': [ { 'start': { 'date-parts': [[2024, 1, 9]],
'date-time': '2024-01-09T00:00:00Z',
'timestamp': 1704758400000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0/'}],
'funder': [ {'name': 'Cariverona Foundation', 'award': ['ENACT Fund 2020']},
{ 'name': 'European Union Horizon 2020 research and innovation programme',
'award': ['1010161671']}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>COVID-19 has been associated with having a negative impact on patients’ gut '
'microbiome during both active disease and in the post-acute phase. In acute COVID-19, rapid '
'alteration of the gut microbiome composition was observed, showing on one side a reduction in '
'beneficial symbionts (e.g., Roseburia, Lachnospiraceae) and on the other side an increase in '
'opportunistic pathogens such as Enterococcus and Proteobacteria. Alpha diversity tends to '
'decrease, especially initially with symptom onset and hospital admission. Although clinical '
'recovery appears to align with improved gut homeostasis, this process could take several '
'weeks, even in mild infections. Moreover, patients with COVID-19 post-acute syndrome showed '
'changes in gut microbiome composition, with specific signatures associated with decreased '
'respiratory function up to 12 months following acute disease. Potential treatments, '
'especially probiotic-based therapy, are under investigation. Open questions remain on the '
'possibility to use gut microbiome data to predict disease progression and on potential '
'confounders that may impair result interpretation (e.g., concomitant therapies in the acute '
'phase; reinfection, vaccines, and occurrence of novel conditions or diseases in the '
'post-acute syndrome). Understanding the relationships between gut microbiome dynamics and '
'disease progression may contribute to better understanding post-COVID syndrome pathogenesis '
'or inform personalized treatment that can affect specific targets or microbiome '
'markers.</jats:p>',
'DOI': '10.3390/microorganisms12010131',
'type': 'journal-article',
'created': {'date-parts': [[2024, 1, 10]], 'date-time': '2024-01-10T10:47:21Z', 'timestamp': 1704883641000},
'page': '131',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Gut Microbiome Disruption Following SARS-CoV-2: A Review',
'prefix': '10.3390',
'volume': '12',
'author': [ { 'ORCID': 'http://orcid.org/0000-0001-8718-1200',
'authenticated-orcid': False,
'given': 'Elda',
'family': 'Righi',
'sequence': 'first',
'affiliation': [ { 'name': 'IMID Laboratory, Department of Diagnostics and Public Health, '
'Infectious Diseases Division, University of Verona, 37134 '
'Verona, Italy'}]},
{ 'given': 'Ilaria',
'family': 'Dalla Vecchia',
'sequence': 'additional',
'affiliation': [ { 'name': 'IMID Laboratory, Department of Diagnostics and Public Health, '
'Infectious Diseases Division, University of Verona, 37134 '
'Verona, Italy'}]},
{ 'given': 'Nina',
'family': 'Auerbach',
'sequence': 'additional',
'affiliation': [ { 'name': 'IMID Laboratory, Department of Diagnostics and Public Health, '
'Infectious Diseases Division, University of Verona, 37134 '
'Verona, Italy'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-1684-0261',
'authenticated-orcid': False,
'given': 'Matteo',
'family': 'Morra',
'sequence': 'additional',
'affiliation': [ { 'name': 'IMID Laboratory, Department of Diagnostics and Public Health, '
'Infectious Diseases Division, University of Verona, 37134 '
'Verona, Italy'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-3305-8711',
'authenticated-orcid': False,
'given': 'Anna',
'family': 'Górska',
'sequence': 'additional',
'affiliation': [ { 'name': 'IMID Laboratory, Department of Diagnostics and Public Health, '
'Infectious Diseases Division, University of Verona, 37134 '
'Verona, Italy'}]},
{ 'given': 'Concetta',
'family': 'Sciammarella',
'sequence': 'additional',
'affiliation': [ { 'name': 'IMID Laboratory, Department of Diagnostics and Public Health, '
'Infectious Diseases Division, University of Verona, 37134 '
'Verona, Italy'}]},
{ 'given': 'Lorenza',
'family': 'Lambertenghi',
'sequence': 'additional',
'affiliation': [ { 'name': 'IMID Laboratory, Department of Diagnostics and Public Health, '
'Infectious Diseases Division, University of Verona, 37134 '
'Verona, Italy'}]},
{ 'given': 'Elisa',
'family': 'Gentilotti',
'sequence': 'additional',
'affiliation': [ { 'name': 'IMID Laboratory, Department of Diagnostics and Public Health, '
'Infectious Diseases Division, University of Verona, 37134 '
'Verona, Italy'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-2342-5867',
'authenticated-orcid': False,
'given': 'Massimo',
'family': 'Mirandola',
'sequence': 'additional',
'affiliation': [ { 'name': 'IMID Laboratory, Department of Diagnostics and Public Health, '
'Infectious Diseases Division, University of Verona, 37134 '
'Verona, Italy'}]},
{ 'given': 'Evelina',
'family': 'Tacconelli',
'sequence': 'additional',
'affiliation': [ { 'name': 'IMID Laboratory, Department of Diagnostics and Public Health, '
'Infectious Diseases Division, University of Verona, 37134 '
'Verona, Italy'}]},
{ 'given': 'Assunta',
'family': 'Sartor',
'sequence': 'additional',
'affiliation': [ { 'name': 'Microbiology Unit, Udine University Hospital, 33100 Udine, '
'Italy'}]}],
'member': '1968',
'published-online': {'date-parts': [[2024, 1, 9]]},
'reference': [ { 'key': 'ref_1',
'doi-asserted-by': 'crossref',
'first-page': '1302',
'DOI': '10.1053/j.gastro.2020.06.048',
'article-title': 'Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During '
'Time of Hospitalization until Discharge',
'volume': '159',
'author': 'Zuo',
'year': '2020',
'journal-title': 'Gastroenterology'},
{ 'key': 'ref_2',
'doi-asserted-by': 'crossref',
'first-page': '2201157',
'DOI': '10.1080/19490976.2023.2201157',
'article-title': 'Gut microbiota in COVID-19: New insights from inside',
'volume': '15',
'author': 'Zhou',
'year': '2023',
'journal-title': 'Gut Microbes'},
{ 'key': 'ref_3',
'doi-asserted-by': 'crossref',
'first-page': '323',
'DOI': '10.1038/s41575-022-00698-4',
'article-title': 'Gut microbiota in COVID-19: Key microbial changes, potential mechanisms '
'and clinical applications',
'volume': '20',
'author': 'Zhang',
'year': '2023',
'journal-title': 'Nat. Rev. Gastroenterol. Hepatol.'},
{ 'key': 'ref_4',
'doi-asserted-by': 'crossref',
'unstructured': 'Righi, E., Lambertenghi, L., Gorska, A., Sciammarella, C., Ivaldi, F., '
'and Mirandola, M. (2022). Assunta Sartor, Evelina Tacconelli. Impact of '
'COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for '
'Enterococcus spp.. Biomedicines, 10.',
'DOI': '10.3390/biomedicines10112786'},
{ 'key': 'ref_5',
'unstructured': '(2023, October 03). Post COVID-19 Condition (Long COVID) [Internet]. '
'Available online: '
'https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.'},
{ 'key': 'ref_6',
'doi-asserted-by': 'crossref',
'first-page': '544',
'DOI': '10.1136/gutjnl-2021-325989',
'article-title': 'Gut microbiota dynamics in a prospective cohort of patients with '
'post-acute COVID-19 syndrome',
'volume': '71',
'author': 'Liu',
'year': '2022',
'journal-title': 'Gut'},
{ 'key': 'ref_7',
'doi-asserted-by': 'crossref',
'first-page': '1230',
'DOI': '10.1136/gutjnl-2022-328319',
'article-title': 'Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year '
'after SARS-CoV-2 clearance',
'volume': '72',
'author': 'Su',
'year': '2023',
'journal-title': 'Gut'},
{ 'key': 'ref_8',
'doi-asserted-by': 'crossref',
'first-page': '220',
'DOI': '10.1016/S0140-6736(20)32656-8',
'article-title': '6-month consequences of COVID-19 in patients discharged from hospital: '
'A cohort study',
'volume': '397',
'author': 'Huang',
'year': '2021',
'journal-title': 'Lancet Lond. Engl.'},
{ 'key': 'ref_9',
'doi-asserted-by': 'crossref',
'first-page': '1579',
'DOI': '10.1007/s40121-021-00461-3',
'article-title': 'Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients '
'with COVID-19',
'volume': '10',
'author': 'Righi',
'year': '2021',
'journal-title': 'Infect. Dis. Ther.'},
{ 'key': 'ref_10',
'doi-asserted-by': 'crossref',
'unstructured': 'Takahashi, S., Tomita, J., Nishioka, K., Hisada, T., and Nishijima, M. '
'(2014). Development of a prokaryotic universal primer for simultaneous '
'analysis of Bacteria and Archaea using next-generation sequencing. PLoS '
'ONE, 9.',
'DOI': '10.1371/journal.pone.0105592'},
{ 'key': 'ref_11',
'doi-asserted-by': 'crossref',
'first-page': '10',
'DOI': '10.14806/ej.17.1.200',
'article-title': 'Cutadapt removes adapter sequences from high-throughput sequencing '
'reads',
'volume': '17',
'author': 'Martin',
'year': '2011',
'journal-title': 'EMBnet. J.'},
{ 'key': 'ref_12',
'doi-asserted-by': 'crossref',
'first-page': '3094',
'DOI': '10.1093/bioinformatics/bty191',
'article-title': 'Minimap2: Pairwise alignment for nucleotide sequences',
'volume': '34',
'author': 'Li',
'year': '2018',
'journal-title': 'Bioinformatics'},
{ 'key': 'ref_13',
'doi-asserted-by': 'crossref',
'first-page': 'D590',
'DOI': '10.1093/nar/gks1219',
'article-title': 'The SILVA ribosomal RNA gene database project: Improved data processing '
'and web-based tools',
'volume': '41',
'author': 'Quast',
'year': '2013',
'journal-title': 'Nucleic Acids Res.'},
{ 'key': 'ref_14',
'doi-asserted-by': 'crossref',
'unstructured': 'Huson, D.H., Beier, S., Flade, I., Górska, A., El-Hadidi, M., Mitra, S., '
'Ruscheweyh, H.J., and Tappu, R. (2016). MEGAN Community '
'Edition—Interactive Exploration and Analysis of Large-Scale Microbiome '
'Sequencing Data. PLoS Comput. Biol., 12.',
'DOI': '10.1371/journal.pcbi.1004957'},
{ 'key': 'ref_15',
'doi-asserted-by': 'crossref',
'first-page': '90',
'DOI': '10.1109/MCSE.2007.55',
'article-title': 'MATPLOTLIB: A 2D Graphics Environment',
'volume': '9',
'author': 'Hunter',
'year': '2007',
'journal-title': 'Comput. Sci. Eng.'},
{ 'key': 'ref_16',
'unstructured': 'Jones, E., Oliphant, T., and Peterson, P. (2023, June 23). SciPy: Open '
'Source Scientific Tools for Python. Available online: '
'https://scipy.org/.'},
{ 'key': 'ref_17',
'doi-asserted-by': 'crossref',
'first-page': '8228',
'DOI': '10.1128/AEM.71.12.8228-8235.2005',
'article-title': 'UniFrac: A new phylogenetic method for comparing microbial communities',
'volume': '71',
'author': 'Lozupone',
'year': '2005',
'journal-title': 'Appl. Environ. Microbiol.'},
{ 'key': 'ref_18',
'unstructured': '(2023, April 20). scikit-bio: A Bioinformatics Library for Data '
'Scientists, Students, and Developers. Available online: '
'https://scikit.bio.'},
{ 'key': 'ref_19',
'doi-asserted-by': 'crossref',
'first-page': '1635',
'DOI': '10.1093/molbev/msw046',
'article-title': 'ETE 3: Reconstruction, Analysis, and Visualization of Phylogenomic Data',
'volume': '33',
'author': 'Serra',
'year': '2016',
'journal-title': 'Mol. Biol. Evol.'},
{ 'key': 'ref_20',
'doi-asserted-by': 'crossref',
'unstructured': 'Gaibani, P., D’Amico, F., Bartoletti, M., Lombardo, D., Rampelli, S., '
'Fornaro, G., Coladonato, S., Siniscalchi, A., Re, M.C., and Viale, P. '
'(2021). The Gut Microbiota of Critically Ill Patients With COVID-19. '
'Front. Cell Infect. Microbiol., 11.',
'DOI': '10.3389/fcimb.2021.670424'},
{ 'key': 'ref_21',
'doi-asserted-by': 'crossref',
'unstructured': 'Mazzarelli, A., Giancola, M.L., Farina, A., Marchioni, L., Rueca, M., '
'Gruber, C.E.M., Bartolini, B., Ascoli Bartoli, T., Maffongelli, G., and '
'Capobianchi, M.R. (2021). 16S rRNA gene sequencing of rectal swab in '
'patients affected by COVID-19. PLoS ONE, 16.',
'DOI': '10.1371/journal.pone.0247041'},
{ 'key': 'ref_22',
'doi-asserted-by': 'crossref',
'unstructured': 'Moreira-Rosário, A., Marques, C., Pinheiro, H., Araújo, J.R., Ribeiro, '
'P., Rocha, R., Mota, I., Pestana, D., Ribeiro, R., and Pereira, A. '
'(2021). Gut Microbiota Diversity and C-Reactive Protein Are Predictors '
'of Disease Severity in COVID-19 Patients. Front. Microbiol., 12.',
'DOI': '10.3389/fmicb.2021.705020'},
{ 'key': 'ref_23',
'doi-asserted-by': 'crossref',
'unstructured': 'Khan, M., Mathew, B.J., Gupta, P., Garg, G., Khadanga, S., Vyas, A.K., '
'and Singh, A.K. (2021). Gut dysbiosis and il-21 response in patients '
'with severe covid-19. Microorganisms, 9.',
'DOI': '10.3390/microorganisms9061292'},
{ 'key': 'ref_24',
'doi-asserted-by': 'crossref',
'unstructured': 'Reinold, J., Farahpour, F., Fehring, C., Dolff, S., Konik, M., Korth, '
'J., van Baal, L., Hoffmann, D., Buer, J., and Witzke, O. (2021). A '
'Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected '
'Patients and a Reduction in the Connectivity of an Anti-Inflammatory '
'Bacterial Network Associates With Severe COVID-19. Front. Cell Infect. '
'Microbiol., 11.',
'DOI': '10.3389/fcimb.2021.747816'},
{ 'key': 'ref_25',
'doi-asserted-by': 'crossref',
'first-page': '1',
'DOI': '10.1080/19490976.2021.1926840',
'article-title': 'The gut microbiome of COVID-19 recovered patients returns to uninfected '
'status in a minority-dominated United States cohort',
'volume': '13',
'author': 'Newsome',
'year': '2021',
'journal-title': 'Gut Microbes'},
{ 'key': 'ref_26',
'doi-asserted-by': 'crossref',
'unstructured': 'Kim, H.N., Joo, E.J., Lee, C.W., Ahn, K.S., Kim, H.L., Park, D.I., and '
'Park, S.K. (2021). Reversion of Gut Microbiota during the Recovery Phase '
'in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study. '
'Microorganisms, 9.',
'DOI': '10.3390/microorganisms9061237'},
{ 'key': 'ref_27',
'doi-asserted-by': 'crossref',
'unstructured': 'Cheng, X., Zhang, Y., Li, Y., Wu, Q., Wu, J., Park, S.K., Guo, C., and '
'Lu, J. (2022). Meta-analysis of 16S rRNA microbial data identified '
'alterations of the gut microbiota in COVID-19 patients during the acute '
'and recovery phases. BMC Microbiol., 22.',
'DOI': '10.1186/s12866-022-02686-9'},
{ 'key': 'ref_28',
'doi-asserted-by': 'crossref',
'unstructured': 'de Nies, L., Galata, V., Martin-Gallausiaux, C., Despotovic, M., Busi, '
'S.B., Snoeck, C.J., Delacour, L., Budagavi, D.P., Laczny, C.C., and '
'Habier, J. (2023). Altered infective competence of the human gut '
'microbiome in COVID-19. Microbiome, 11.',
'DOI': '10.1101/2022.10.20.512999'},
{ 'key': 'ref_29',
'doi-asserted-by': 'crossref',
'first-page': '906',
'DOI': '10.3389/fimmu.2020.00906',
'article-title': 'The Genus Alistipes: Gut Bacteria With Emerging Implications to '
'Inflammation, Cancer, and Mental Health',
'volume': '11',
'author': 'Parker',
'year': '2020',
'journal-title': 'Front. Immunol.'},
{ 'key': 'ref_30',
'doi-asserted-by': 'crossref',
'first-page': '102107',
'DOI': '10.1016/j.eclinm.2023.102107',
'article-title': 'Clinical phenotypes and quality of life to define post-COVID-19 '
'syndrome: A cluster analysis of the multinational, prospective '
'ORCHESTRA cohort',
'volume': '62',
'author': 'Gentilotti',
'year': '2023',
'journal-title': 'EClinicalMedicine'},
{ 'key': 'ref_31',
'doi-asserted-by': 'crossref',
'first-page': '566',
'DOI': '10.1016/j.jinf.2022.02.003',
'article-title': 'Determinants of persistence of symptoms and impact on physical and '
'mental wellbeing in Long COVID: A prospective cohort study',
'volume': '84',
'author': 'Righi',
'year': '2022',
'journal-title': 'J. Infect.'},
{ 'key': 'ref_32',
'doi-asserted-by': 'crossref',
'first-page': '222',
'DOI': '10.1136/gutjnl-2021-324090',
'article-title': 'Six-month follow-up of gut microbiota richness in patients with '
'COVID-19',
'volume': '71',
'author': 'Chen',
'year': '2022',
'journal-title': 'Gut'},
{ 'key': 'ref_33',
'doi-asserted-by': 'crossref',
'first-page': '941',
'DOI': '10.1007/s12275-021-1206-5',
'article-title': 'Linking the gut microbiota to persistent symptoms in survivors of '
'COVID-19 after discharge',
'volume': '59',
'author': 'Zhou',
'year': '2021',
'journal-title': 'J. Microbiol.'},
{ 'key': 'ref_34',
'doi-asserted-by': 'crossref',
'first-page': '801',
'DOI': '10.1111/joim.13458',
'article-title': 'Respiratory dysfunction three months after severe COVID-19 is '
'associated with gut microbiota alterations',
'volume': '291',
'author': 'Vestad',
'year': '2022',
'journal-title': 'J. Intern. Med.'},
{ 'key': 'ref_35',
'doi-asserted-by': 'crossref',
'first-page': '6806',
'DOI': '10.1038/s41467-022-34535-8',
'article-title': 'Multi-kingdom gut microbiota analyses define COVID-19 severity and '
'post-acute COVID-19 syndrome',
'volume': '13',
'author': 'Liu',
'year': '2022',
'journal-title': 'Nat. Commun.'},
{ 'key': 'ref_36',
'first-page': '376',
'article-title': 'Inflammation-associated gut microbiome in postacute sequelae of '
'SARS-CoV-2 points towards new therapeutic targets',
'volume': '73',
'author': 'Carneiro',
'year': '2023',
'journal-title': 'Gut'},
{ 'key': 'ref_37',
'doi-asserted-by': 'crossref',
'first-page': 'e120',
'DOI': '10.3346/jkms.2023.38.e120',
'article-title': 'Gut Microbiota Dysbiosis Correlates With Long COVID-19 at One-Year '
'After Discharge',
'volume': '38',
'author': 'Zhang',
'year': '2023',
'journal-title': 'J. Korean Med. Sci.'},
{ 'key': 'ref_38',
'doi-asserted-by': 'crossref',
'first-page': '506',
'DOI': '10.1038/nrgastro.2014.66',
'article-title': 'The International Scientific Association for Probiotics and Prebiotics '
'consensus statement on the scope and appropriate use of the term '
'probiotic',
'volume': '11',
'author': 'Hill',
'year': '2014',
'journal-title': 'Nat. Rev. Gastroenterol. Hepatol.'},
{ 'key': 'ref_39',
'doi-asserted-by': 'crossref',
'unstructured': 'Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., Seifan, M., '
'Mohkam, M., Masoumi, S.J., Berenjian, A., and Ghasemi, Y. (2019). '
'Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical '
'Applications. Foods, 8.',
'DOI': '10.3390/foods8030092'},
{ 'key': 'ref_40',
'doi-asserted-by': 'crossref',
'first-page': '907',
'DOI': '10.1038/s12276-021-00627-6',
'article-title': 'Gut microbiota restoration through fecal microbiota transplantation: A '
'new atopic dermatitis therapy',
'volume': '53',
'author': 'Kim',
'year': '2021',
'journal-title': 'Exp. Mol. Med.'},
{ 'key': 'ref_41',
'doi-asserted-by': 'crossref',
'unstructured': 'Alenazy, M.F., Aljohar, H.I., Alruwaili, A.R., Daghestani, M.H., '
'Alonazi, M.A., Labban, R.S., El-Ansary, A.K., and Balto, H.A. (2022). '
'Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of '
'Probiotics to Combat Psychiatric Complications. Metabolites, 12.',
'DOI': '10.3390/metabo12100912'},
{ 'key': 'ref_42',
'doi-asserted-by': 'crossref',
'first-page': '698',
'DOI': '10.1136/gutjnl-2020-323020',
'article-title': 'Gut microbiota composition reflects disease severity and dysfunctional '
'immune responses in patients with COVID-19',
'volume': '70',
'author': 'Yeoh',
'year': '2021',
'journal-title': 'Gut'},
{ 'key': 'ref_43',
'doi-asserted-by': 'crossref',
'first-page': '1180',
'DOI': '10.1017/S0007114521001926',
'article-title': 'Beyond probiotic legend: ESSAP gut microbiota health score to delineate '
'SARS-COV-2 infection severity',
'volume': '127',
'author': 'Hegazy',
'year': '2022',
'journal-title': 'Br. J. Nutr.'},
{ 'key': 'ref_44',
'doi-asserted-by': 'crossref',
'first-page': '187',
'DOI': '10.1016/j.tifs.2020.12.009',
'article-title': 'Review article: Probiotics, prebiotics and dietary approaches during '
'COVID-19 pandemic',
'volume': '108',
'author': 'Hu',
'year': '2021',
'journal-title': 'Trends Food Sci. Technol.'},
{ 'key': 'ref_45',
'doi-asserted-by': 'crossref',
'first-page': '327',
'DOI': '10.1111/j.1365-2036.2011.04939.x',
'article-title': 'Randomised clinical trial: The effectiveness of Lactobacillus reuteri '
'ATCC 55730 rectal enema in children with active distal ulcerative '
'colitis',
'volume': '35',
'author': 'Oliva',
'year': '2012',
'journal-title': 'Aliment. Pharmacol. Ther.'},
{ 'key': 'ref_46',
'doi-asserted-by': 'crossref',
'first-page': '186',
'DOI': '10.3389/fpubh.2020.00186',
'article-title': 'Using probiotics to flatten the curve of coronavirus disease COVID-2019 '
'pandemic',
'volume': '8',
'author': 'Baud',
'year': '2020',
'journal-title': 'Front. Public Health'},
{ 'key': 'ref_47',
'doi-asserted-by': 'crossref',
'unstructured': 'Din, A.U., Mazhar, M., Waseem, M., Ahmad, W., Bibi, A., Hassan, A., Ali, '
'N., Gang, W., Qian, G., and Ullah, R. (2021). SARS-CoV-2 microbiome '
'dysbiosis linked disorders and possible probiotics role. Biomed '
'Pharmacother. Biomed. Pharmacother., 133.',
'DOI': '10.1016/j.biopha.2020.110947'},
{ 'key': 'ref_48',
'doi-asserted-by': 'crossref',
'first-page': '39',
'DOI': '10.1002/eji.201646721',
'article-title': 'Contributions of the intestinal microbiome in lung immunity',
'volume': '48',
'author': 'McAleer',
'year': '2018',
'journal-title': 'Eur. J. Immunol.'},
{ 'key': 'ref_49',
'doi-asserted-by': 'crossref',
'first-page': '97',
'DOI': '10.1038/s41590-018-0260-6',
'article-title': 'The establishment of resident memory B cells in the lung requires local '
'antigen encounter',
'volume': '20',
'author': 'Allie',
'year': '2019',
'journal-title': 'Nat. Immunol.'},
{ 'key': 'ref_50',
'doi-asserted-by': 'crossref',
'unstructured': 'Wong, M.C.S., Zhang, L., Ching, J.Y.L., Mak, J.W.Y., Huang, J., Wang, '
'S., Mok, C.K.P., Wong, A., Chiu, Q.L., and Fung, J.T. (2023). Effects of '
'Gut Microbiome Modulation on Reducing Adverse Health Outcomes among '
'Elderly and Diabetes Patients during the COVID-19 Pandemic: A '
'Randomised, Double-Blind, Placebo-Controlled Trial (IMPACT Study). '
'Nutrients, 15.',
'DOI': '10.3390/nu15081982'},
{ 'key': 'ref_51',
'doi-asserted-by': 'crossref',
'first-page': '823',
'DOI': '10.1111/jgh.15796',
'article-title': 'Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant '
'therapy for COVID-19: An open-label pilot study',
'volume': '37',
'author': 'Zhang',
'year': '2022',
'journal-title': 'J. Gastroenterol. Hepatol.'},
{ 'key': 'ref_52',
'doi-asserted-by': 'crossref',
'unstructured': 'Wischmeyer, P., Tang, H., Ren, Y., Bohannon, L., Ramirez, Z., Andermann, '
'T., Messina, J.A., Sung, J.A., Jensen, D., and Jung, S. (2023, October '
'03). Efficacy of Probiotic Treatment as Post-Exposure Prophylaxis for '
'COVID-19: A Double-Blind, Placebo Controlled Randomized Tria [Internet]. '
'Available online: https://europepmc.org/article/PPR/PPR545983.',
'DOI': '10.21203/rs.3.rs-1930760/v1'},
{ 'key': 'ref_53',
'doi-asserted-by': 'crossref',
'first-page': 'e01282-19',
'DOI': '10.1128/JVI.01282-19',
'article-title': 'Peptidoglycan-Associated Cyclic Lipopeptide Disrupts Viral Infectivity',
'volume': '93',
'author': 'Johnson',
'year': '2019',
'journal-title': 'J. Virol.'},
{ 'key': 'ref_54',
'doi-asserted-by': 'crossref',
'first-page': '2018899',
'DOI': '10.1080/19490976.2021.2018899',
'article-title': 'Probiotic improves symptomatic and viral clearance in Covid19 '
'outpatients: A randomized, quadruple-blinded, placebo-controlled trial',
'volume': '14',
'year': '2022',
'journal-title': 'Gut Microbes'},
{ 'key': 'ref_55',
'doi-asserted-by': 'crossref',
'first-page': '613928',
'DOI': '10.3389/fnut.2020.613928',
'article-title': 'Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort '
'Study',
'volume': '7',
'author': 'Ceccarelli',
'year': '2020',
'journal-title': 'Front. Nutr.'},
{ 'key': 'ref_56',
'doi-asserted-by': 'crossref',
'first-page': '17562848211035670',
'DOI': '10.1177/17562848211035670',
'article-title': 'Probiotics use is associated with improved clinical outcomes among '
'hospitalized patients with COVID-19',
'volume': '14',
'author': 'Zhang',
'year': '2021',
'journal-title': 'Ther. Adv. Gastroenterol.'},
{ 'key': 'ref_57',
'doi-asserted-by': 'crossref',
'first-page': 'e0071121',
'DOI': '10.1128/mSphere.00711-21',
'article-title': 'Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human '
'Microbiome Commensals',
'volume': '6',
'author': 'Piscotta',
'year': '2021',
'journal-title': 'Msphere'},
{ 'key': 'ref_58',
'doi-asserted-by': 'crossref',
'first-page': '903',
'DOI': '10.1080/17474124.2023.2250716',
'article-title': 'Therapeutics for Clostridioides difficile infection: Molecules and '
'microbes',
'volume': '17',
'author': 'Khanna',
'year': '2023',
'journal-title': 'Expert. Rev. Gastroenterol. Hepatol.'},
{ 'key': 'ref_59',
'doi-asserted-by': 'crossref',
'first-page': '230',
'DOI': '10.1136/gutjnl-2021-325010',
'article-title': 'Rapid resolution of COVID-19 after faecal microbiota transplantation',
'volume': '71',
'author': 'Winter',
'year': '2022',
'journal-title': 'Gut'},
{ 'key': 'ref_60',
'doi-asserted-by': 'crossref',
'first-page': '60',
'DOI': '10.1186/s13256-020-02583-7',
'article-title': 'Gastrointestinal disturbance and effect of fecal microbiota '
'transplantation in discharged COVID-19 patients',
'volume': '15',
'author': 'Liu',
'year': '2021',
'journal-title': 'J. Med. Case Rep.'}],
'container-title': 'Microorganisms',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.mdpi.com/2076-2607/12/1/131/pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2024, 1, 10]],
'date-time': '2024-01-10T12:11:55Z',
'timestamp': 1704888715000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.mdpi.com/2076-2607/12/1/131'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2024, 1, 9]]},
'references-count': 60,
'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2024, 1]]}},
'alternative-id': ['microorganisms12010131'],
'URL': 'http://dx.doi.org/10.3390/microorganisms12010131',
'relation': {},
'ISSN': ['2076-2607'],
'subject': ['Virology', 'Microbiology (medical)', 'Microbiology'],
'container-title-short': 'Microorganisms',
'published': {'date-parts': [[2024, 1, 9]]}}
